$125.97 -1.43 (-1.12%) Biomarin Pharmaceutical Inc - NASDAQ

May. 29, 2015 | 01:08 PM
Key Statistics
Last Trade: 125.97
Trade Time: May 29 01:08 PM Eastern Daylight Time
Change: -1.43 (-1.12%)
Prev Close: 127.39
Open: 127.73
Bid: 125.87
Ask: 125.98

Competitors

Ticker Name Volume % Change
AMRN Amarin Corp Shs Sponsored American Deposit Receipt Repr 1 Sh 21.66M +18.97%
PFE Pfizer Inc 15.82M +0.41%
ABBV AbbVie Inc 12.89M +0.13%
RXII RXi Pharmaceuticals Corp 9.66M -16.48%
XOMA Xoma Corp 9.51M +7.83%

BMRN Stock Analysis

Partner Headlines

  1. Sarepta Soars On New Hope For Muscular-Dystrophy Drug

    IBD | May. 20, 2015 | 11:45AM EST
  2. Alexion's $8.4 Billion Synageva Buyout Spooks Street

    IBD | May. 6, 2015 | 18:20PM EST
  3. BIOMARIN PHARMA

    IBD | Apr. 30, 2015 | 18:40PM EST
  4. BioMarin Completes Rolling NDA Submission to FDA for Drisapersen for Treatment of ...

    Benzinga | Apr. 27, 2015 | 09:44AM EST
  5. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus | Apr. 14, 2015 | 21:01PM EST
  6. What Evercore Is Watching At BioMarin Pharmaceutical

    Benzinga | Feb. 25, 2015 | 17:17PM EST